AmirHosseinKashaniMDPhD

Retinal Disease

Associate Professor of Ophthalmology, Wilmer Eye Institute of the Johns Hopkins University

Dr. Kashani is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
10753 Falls Road
Pavilion II STE 455
Lutherville, MD 21093
Phone+1 410-583-2800

Fax+1 410-583-2842

University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Ophthalmology, 2007 - 2010
Johns Hopkins UniversityInternship, Internal Medicine, 2006 - 2007
Johns Hopkins University School of MedicineClass of 2006

PubMed

173 citations
OCT angiography in healthy human subjects.
Douglas Matsunaga, Jack Yi, Carmen A. Puliafito, Amir H. Kashani
Ophthalmic Surgery, Lasers & Imaging Retina. 2014-11-01
60 citations
Past, present and future role of retinal imaging in neurodegenerative disease.
Amir H. Kashani, Samuel Asanad, Jane W. Chan, Maxwell Singer, Jiong Zhang
Progress in Retinal and Eye Research. 2021-01-15
47 citations
The efficacy of curcuminoids in improvement of ulcerative colitis symptoms and patients' self-reported well-being: A randomized double-blind controlled trial.
Mohsen Masoodi, Mohammad Ali Mahdiabadi, Marjan Mokhtare, Sharam Agah, Amir H. Kashani
Journal of Cellular Biochemistry. 2018-11-01

Journal Articles

Original Article Suspended Scattering Particles in Motion: A Novel Feature of OCT Angiography in Exudative Maculopathies
Philip J Rosenfeld, Amir H Kashani, Kyle M Green, Julie Kwon, K Bailey Freund, David Sarraf, Nadia K Waheed, Carl B Rebhun, ScienceDirect

First U.S. Patient Receives Autologous Stem Cell Therapy to Treat Dry AMDSeptember 2nd, 2022
First US Patient Gets Autologous Stem Cell Therapy to Treat Dry AMDSeptember 1st, 2022
Regenerative Patch Technologies Presents Clinical Data Demonstrating Long-Term Survival and Function of an Allogenic Bioengineered Cellular Implant in Patients with Advanced Dry Aged-Related Macular DegenerationFebruary 4th, 2022
Join now to see all